IP Library Granted Patent US 7,101,993
Granted Patent B1
US 7,101,993 · App. 07/967,267 · Granted Sep 5, 2006

Oligonucleotides containing 2′-O-modified purines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,101,993
App. No.
07/967,267
Granted
Sep 5, 2006
Kind
B1
Abstract

Compounds are provided containing purine nucleotides that bear moieties X at the 2′ position thereof wherein X is R 1 —(R 2 ) n ; R 1 is C 3 -C 20 alkyl, C 4 -C 20 alkenyl or C 2 -C 20 alkynyl; R 2 is halogen, hydroxyl, thiol, keto, carboxyl, nitro, nitroso, nitrile, trifluoromethyl, trifluoromethoxy, O-alkyl, S-alkyl, NH-alkyl, N-dialkyl, O-aryl, S-aryl, NH-aryl, O-aralkyl, S-aralkyl, NH-aralkyl, amino, N-phthalimido, imidazole, azido, hydrazino, hydroxylamino, isocyanato, sulfoxide, sulfone, sulfide, disulfide, silyl, aryl, heterocycle, carbocycle, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, a group that enhances the pharmacodynamic properties of oligonucleotides, or a group that enhances the pharmacokinetic properties of oligonucleotides; and n is an integer from 0 to about 6. Such compounds are useful for modulating the synthesis of proteins.

Claims (37)

1. A compound having the structure:

wherein

X is R 1 —(R 2 ) n ;

R 1 is C 2 -C 20 alkyl, C 2 -C 20 alkenyl, or C 2 -C 20 alkynyl and n is 1 to 6;

R 2 is halogen, nitro, nitroso, nitrile, trifluoromethyl, trifluoromethoxy, O-alkyl, S-alkyl, NH-alkyl, N-dialkyl, O-aryl, S-aryl, NH-aryl, O-aralkyl, S-aralkyl, NH-aralkyl, imidazole, N-phthalimido, azido, hydrazino, hydroxylamino, isocyanato, sulfoxide, sulfone, sulfide, disulfide, silyl, aryl, heterocycle, carbocycle, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, or polyether; and

either one of T 3 and T 5 is OH, a hydroxyl blocking group, phosphate or an activated phosphate group and the other of T 3 and T 5 is a nucleotide or both T 3 and T 5 are nucleotides.

2. A compound having the structure:

wherein

X is R 1 —(R 2 ) n ;

R 1 is C 1 -C 20 alkyl, C 4 -C 20 alkenyl, or C 2 -C 20 alkynyl;

R 2 is halogen, nitro, nitroso, nitrile, trifluoromethyl, trifluoromethoxy, O-alkyl, S-alkyl, NH-alkyl, N-dialkyl, O-aryl, S-aryl, NH-aryl, O-aralkyl, S-aralkyl, NH-aralkyl, imidazole, N-phthalimido, azido, hydrazino, hydroxylamino, isocyanato, sulfoxide, sulfone, sulfide, disulfide, silyl, aryl, heterocycle, carbocycle, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, or polyether;

either one of T 3 and T 5 is OH, a hydroxyl blocking group, phosphate or an activated phosphate group and the other of T 3 and T 5 is a nucleotide, or both T 3 and T 5 are nucleotides; and

n is an integer from 1 to 6.

3. The compound of claim 1 wherein R 1 is C 4 -C 20 alkyl.

4. The compound of claim 1 wherein R 1 is C 5 -C 20 alkyl.

5. The compound of claim 1 wherein R 1 is C 3 -C 20 alkyl and n is 1.

6. The compound of claim 1 wherein R 1 is C 4 -C 20 alkenyl and n is 1.

7. The compound of claim 1 wherein R 1 is C 2 -C 20 alkynyl and n is 1.

8. The compound of claim 1 wherein R 1 is C 2 -C 20 alkyl and n is 1 to 6.

9. The compound of claim 1 wherein R 1 is C 2 -C 20 alkenyl and n is 1 to 6.

10. The compound of claim wherein R 1 is C 2 -C 20 alkynyl and n is 1 to 6.

11. The compound of claim 2 wherein R 1 is C 1 -C 20 alkyl.

12. The compound of claim 2 wherein R 1 is C 4 -C 20 alkenyl.

13. The compound of claim 2 wherein R 1 is C 2 -C 20 alkynyl.

14. A compound having the structure:

wherein

X is R 1 —(R 2 ) n ;

R 1 is C 4 -C 20 alkyl, C 4 -C 20 alkenyl, or C 2 -C 20 alkynyl and n is 0; or R 1 is C 1 -C 20 alkyl, C 2 -C 20 alkenyl, or C 2 -C 20 alkynyl and n is 1 to 6;

R 2 is hydroxyl, thiol, keto, carboxyl, or amino; and

either one of T 3 and T 5 is OH, a hydroxyl blocking group, phosphate or an activated phosphate group and the other of T 3 and T 5 is a nucleotide or both T 3 and T 5 are nucleotides.

15. A compound having the structure:

wherein

X is R 1 —(R 2 ) n ;

R 1 is C 1 -C 20 alkyl, C 4 -C 20 alkenyl, or C 2 -C 20 alkynyl;

R 2 is hydroxyl, thiol, keto, carboxyl, or amino;

either one of T 3 and T 5 is OH, a hydroxyl blocking group, phosphate or an activated phosphate group and the other of T 3 and T 5 is a nucleotide, or both T 3 and T 5 are nucleotides; and

n is an integer from 0 to 6.

Assignments (1)
CHANGE OF NAME Recorded Jul 26, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043341/0571 →